Insights on the Basal Cell Carcinoma Treatment Paradigm: Current Standards of Care and Emerging Approaches: A Care Team Forum^℠

Program Overview

The goal of this activity is to educate physicians and other healthcare professionals on the appropriate management of patients with BCC at different disease stages.

Credit Expired

0.75 CE Credit(s)

Expires: June 14, 2022

Target Audience

This activity is intended for oncology, dermatology, and dermato-oncology clinicians who manage patients with basal cell carcinoma (BCC).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Distinguish between high- and low-risk BCC
Apply the current standard of care for treating high-risk BCC
Select appropriate front-line systemic therapy for advanced BCC
Evaluate emerging efficacy and safety data for immunotherapy in advanced BCC, offering clinical trial enrollment where appropriate

Activity Faculty

Prof. Ralf Gutzmer, MD (Chair)

Director
Department of Dermatology
Skin Cancer Center Minden
Johannes-Wesling-Klinikum Minden/Ruhr-University Bochum
Minden, Germany

Prof. Nicole Basset-Seguin, MD, PhD

Policlinique de Dermatologie
Hôpital Saint-Louis
Université de Paris
Paris, France

Omid Hamid, MD

Chief of Research/Immuno-Oncology
The Angeles Clinic & Research Institute
Co-Director, Cutaneous Malignancy Program
Cedars-Sinai CANCER
Los Angeles, California, United States

Thomas Hunter (Patient)

Featured RMEI CE Activities

Climbing the Ladder to Optimal Outcomes in NTM-LD: Navigating a Clear Path from Diagnosis Thru Treatment

Halting the Vicious Vortex: Targeting Neutrophil Serine Protease Activation in Non-Cystic Fibrosis Bronchiectasis (NCFBE)

Tackling Treatment-Refractory and Drug-Resistant CMV in the Solid Organ Transplant Setting: A Care Team Forum®

Optimizing Biologic Therapy in Children with Moderate-to-Severe Atopic Dermatitis: A Care Team Forum®

Privacy | Terms of Use

Insights on the Basal Cell Carcinoma Treatment Paradigm: Current Standards of Care and Emerging Approaches: A Care Team Forum^℠

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Prof. Ralf Gutzmer, MD (Chair)

Prof. Nicole Basset-Seguin, MD, PhD

Omid Hamid, MD

Thomas Hunter (Patient)

Climbing the Ladder to Optimal Outcomes in NTM-LD: Navigating a Clear Path from Diagnosis Thru Treatment

Halting the Vicious Vortex: Targeting Neutrophil Serine Protease Activation in Non-Cystic Fibrosis Bronchiectasis (NCFBE)

Tackling Treatment-Refractory and Drug-Resistant CMV in the Solid Organ Transplant Setting: A Care Team Forum®

Optimizing Biologic Therapy in Children with Moderate-to-Severe Atopic Dermatitis: A Care Team Forum®

Join Our Network

Company

CE Accreditation

HIPAA Verified & Compliant

Subscribe

Insights on the Basal Cell Carcinoma Treatment Paradigm: Current Standards of Care and Emerging Approaches: A Care Team Forum℠

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Prof. Ralf Gutzmer, MD (Chair)

Prof. Nicole Basset-Seguin, MD, PhD

Omid Hamid, MD

Thomas Hunter (Patient)

Climbing the Ladder to Optimal Outcomes in NTM-LD: Navigating a Clear Path from Diagnosis Thru Treatment

Halting the Vicious Vortex: Targeting Neutrophil Serine Protease Activation in Non-Cystic Fibrosis Bronchiectasis (NCFBE)

Tackling Treatment-Refractory and Drug-Resistant CMV in the Solid Organ Transplant Setting: A Care Team Forum®

Optimizing Biologic Therapy in Children with Moderate-to-Severe Atopic Dermatitis: A Care Team Forum®

Subscribe

Insights on the Basal Cell Carcinoma Treatment Paradigm: Current Standards of Care and Emerging Approaches: A Care Team Forum^℠